Fasidotril Eli Lilly
Current Opinion in Investigational Drugs, cilt.4, sa.9, ss.1113-1119, 2003 (Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 4 Sayı: 9
- Basım Tarihi: 2003
- Dergi Adı: Current Opinion in Investigational Drugs
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.1113-1119
- Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır
Özet
Lilly is developing fasidotril, a diester prodrug of the active metabolite fasidotrilat, for the potential treatment of hypertension and congestive heart failure (CHF). Phase II trials to investigate the potential of fasidotril for the treatment of hypertension and CHF had commenced by the late 1990s, and were ongoing in July 2003 in the US and Europe. © Current Drugs.